RYAHF (RYAH Group) Treasury Stock: $0.00 Mil (As of Sep. 2022)


What is RYAH Group Treasury Stock?

RYAH Group RYAHF Treasury Stock is $0.00 Mil as of Sep. 2022.

Treasury stock is the portion of shares that a company keeps in their own treasury. RYAH Group's treasury stock for the quarter that ended in Sep. 2022 was $0.00 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

RYAH Group Treasury Stock Historical Data

* Premium members only.

The historical data trend for RYAH Group's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RYAH Group Treasury Stock Chart

RYAH Group Annual Data
Trend Dec20 Dec21
Treasury Stock
0.00 0.00

RYAH Group Quarterly Data
Feb20 Dec20 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Treasury Stock Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

RYAH Group Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Frequently Asked Questions Learn more about Treasury Stock →
What does a Treasury Stock of $0.00 Mil mean?
RYAH Group (RYAHF) has a Treasury Stock of $0.00 Mil as of Sep. 2022. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for RYAH Group and its competitors.
Is RYAH Group's Treasury Stock too high?
RYAH Group's current Treasury Stock is $0.00 Mil.
How does RYAH Group's Treasury Stock compare to CERN and VEEV?
RYAH Group's Treasury Stock of $0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Treasury Stock for a Healthcare Providers & Services company?
A good Treasury Stock depends on the Healthcare Providers & Services industry context. However, Treasury Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Treasury Stock mean?
A high Treasury Stock can signal that a stock is expensive relative to its fundamentals. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for RYAH Group and its competitors. RYAH Group's current Treasury Stock is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RYAH Group stock overvalued right now?
RYAH Group (RYAHF) has a current Treasury Stock of $0.00 Mil. The current Treasury Stock is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Treasury Stock calculated?
Treasury Stock is calculated from a company's financial statements. For RYAH Group (RYAHF), the current Treasury Stock is $0.00 Mil as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RYAH Group Business Description

Address 68 34TH STREET, SUITE B421, BROOKLYN, NY, USA, 11232
RYAH Group Inc is a data technology company in plant-based medicine. Its Artificial Intelligence platform aggregates and correlates HIPAA-compliant dosing data from seed to consumption. This helps the company to conduct predictive analyses to help doctors, researchers, and end-users create personalized dosing regimens that can accurately foresee patient outcomes. the company also provide other products which are smart inhaler system & smart patch system.